178 related articles for article (PubMed ID: 15134361)
21. Comparison of the effects of antimicrobial agents from three different classes on metabolism of isoflavonoids by colonic microflora using Etest strips.
Sutherland JB; Bridges BM; Heinze TM; Adams MR; Delio PJ; Hotchkiss C; Rafii F
Curr Microbiol; 2012 Jan; 64(1):60-5. PubMed ID: 22006071
[TBL] [Abstract][Full Text] [Related]
22. Isolation and identification of equol-producing bacterial strains from cultures of pig faeces.
Yu ZT; Yao W; Zhu WY
FEMS Microbiol Lett; 2008 May; 282(1):73-80. PubMed ID: 18328079
[TBL] [Abstract][Full Text] [Related]
23. Ileal and faecal digestibility of daidzein and genistein and plasma bioavailability of these isoflavones and their bioactive metabolites in the ovariectomised rat.
Poulsen RC; Loots du T; Moughan PJ; Kruger MC
Mol Nutr Food Res; 2009 May; 53 Suppl 1():S27-35. PubMed ID: 19156712
[TBL] [Abstract][Full Text] [Related]
24. Metabolism of dietary soy isoflavones to equol by human intestinal microflora--implications for health.
Yuan JP; Wang JH; Liu X
Mol Nutr Food Res; 2007 Jul; 51(7):765-81. PubMed ID: 17579894
[TBL] [Abstract][Full Text] [Related]
25. Concentrations of isoflavones in macaques consuming standard laboratory monkey diet.
Stroud FC; Appt SE; Wilson ME; Franke AA; Adams MR; Kaplan JR
J Am Assoc Lab Anim Sci; 2006 Jul; 45(4):20-3. PubMed ID: 16884174
[TBL] [Abstract][Full Text] [Related]
26. R(-)-O-desmethylangolensin is the main enantiomeric form of daidzein metabolite produced by human in vitro and in vivo.
Gardana C; Canzi E; Simonetti P
J Chromatogr B Analyt Technol Biomed Life Sci; 2014 Mar; 953-954():30-7. PubMed ID: 24561352
[TBL] [Abstract][Full Text] [Related]
27. Metabolism of daidzein by Nocardia species NRRL 5646 and Mortierella isabellina ATCC 38063.
Maatooq GT; Rosazza JP
Phytochemistry; 2005 May; 66(9):1007-11. PubMed ID: 15896369
[TBL] [Abstract][Full Text] [Related]
28. Dihydrodaidzein-producing Clostridium-like intestinal bacterium, strain TM-40, affects in vitro metabolism of daidzein by fecal microbiota of human male equol producer and non-producers.
Tamura M; Hori S; Nakagawa H
Biosci Microflora; 2011; 30(3):65-71. PubMed ID: 25045313
[TBL] [Abstract][Full Text] [Related]
29. Enantioselective synthesis of S-equol from dihydrodaidzein by a newly isolated anaerobic human intestinal bacterium.
Wang XL; Hur HG; Lee JH; Kim KT; Kim SI
Appl Environ Microbiol; 2005 Jan; 71(1):214-9. PubMed ID: 15640190
[TBL] [Abstract][Full Text] [Related]
30. Isolation of human intestinal bacteria metabolizing the natural isoflavone glycosides daidzin and genistin.
Hur HG; Lay JO; Beger RD; Freeman JP; Rafii F
Arch Microbiol; 2000 Dec; 174(6):422-8. PubMed ID: 11195098
[TBL] [Abstract][Full Text] [Related]
31. Lactulose promotes equol production and changes the microbial community during in vitro fermentation of daidzein by fecal inocula of sows.
Zheng W; Hou Y; Su Y; Yao W
Anaerobe; 2014 Feb; 25():47-52. PubMed ID: 24315807
[TBL] [Abstract][Full Text] [Related]
32. Is equol production beneficial to health?
Magee PJ
Proc Nutr Soc; 2011 Feb; 70(1):10-8. PubMed ID: 21092366
[TBL] [Abstract][Full Text] [Related]
33. Isolation and characterisation of an equol-producing mixed microbial culture from a human faecal sample and its activity under gastrointestinal conditions.
Decroos K; Vanhemmens S; Cattoir S; Boon N; Verstraete W
Arch Microbiol; 2005 Jan; 183(1):45-55. PubMed ID: 15578160
[TBL] [Abstract][Full Text] [Related]
34. Relative Inhibitions of 5-Lipoxygenase and Myeloperoxidase and Free-Radical Scavenging Activities of Daidzein, Dihydrodaidzein, and Equol.
Tsen SY; Tan XY; Tan YM; Yan BY; Loke WM
J Med Food; 2016 Jun; 19(6):543-8. PubMed ID: 27027338
[TBL] [Abstract][Full Text] [Related]
35. Microbial equol production attenuates colonic methanogenesis and sulphidogenesis in vitro.
Bolca S; Verstraete W
Anaerobe; 2010 Jun; 16(3):247-52. PubMed ID: 20298796
[TBL] [Abstract][Full Text] [Related]
36. Effects of an equol-producing bacterium isolated from human faeces on isoflavone and lignan metabolism in mice.
Tamura M; Hori S; Nakagawa H; Yamauchi S; Sugahara T
J Sci Food Agric; 2016 Jul; 96(9):3126-32. PubMed ID: 26455424
[TBL] [Abstract][Full Text] [Related]
37. Studies on the antioxidant properties of some phytoestrogens.
Kładna A; Berczyński P; Kruk I; Piechowska T; Aboul-Enein HY
Luminescence; 2016 Sep; 31(6):1201-6. PubMed ID: 26799817
[TBL] [Abstract][Full Text] [Related]
38. Differences in fecal excretion of cholesterol and bacterial degradation products in high- and low-responding rhesus monkeys: implications in colon cancer.
Bhattacharyya AK; Eggen DA; Correa P; Strong JP
Nutr Cancer; 1989; 12(1):69-73. PubMed ID: 2496397
[TBL] [Abstract][Full Text] [Related]
39. Isolation and identification of an isoflavone reducing bacterium from feces from a pregnant horse.
Jinglong X; Xiaobin L; Fang Z; Chenchen W; Kailun Y
PLoS One; 2019; 14(11):e0223503. PubMed ID: 31738752
[TBL] [Abstract][Full Text] [Related]
40. Vasorelaxant and antioxidant activity of the isoflavone metabolite equol in carotid and cerebral arteries.
Jackman KA; Woodman OL; Chrissobolis S; Sobey CG
Brain Res; 2007 Apr; 1141():99-107. PubMed ID: 17274967
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]